St. Joseph's Healthcare Hamilton

Breathing new life into patient care: Innovative partnership aims to transform interstitial lung disease support

Retrieved on: 
Wednesday, October 25, 2023

"Having the opportunity to work with ILD patients has been a deeply humbling and rewarding experience.

Key Points: 
  • "Having the opportunity to work with ILD patients has been a deeply humbling and rewarding experience.
  • "ILD is a complex, life-altering disease where Canadians often do not get the information they need at diagnosis.
  • Boehringer Ingelheim Canada, St. Joseph's Healthcare Hamilton, and McMaster University are committed to transforming the ILD patient experience.
  • Research is wide-ranging, from basic studies of animal models of lung disease (asthma, COPD, fibrosis) to clinical trials, epidemiological studies, and evaluative research.

Insight Medbotics Announces World's First FDA-Cleared, MRI-Compatible Robot

Retrieved on: 
Wednesday, September 13, 2023

IGAR is the first and only robotics system designed to work inside an MRI bore to achieve this regulatory clearance.

Key Points: 
  • IGAR is the first and only robotics system designed to work inside an MRI bore to achieve this regulatory clearance.
  • Insight Medbotics has demonstrated IGAR's safety and efficacy through published clinical studies in breast biopsy.
  • Insight Medbotics was subsequently launched as a start-up company by CSii and MDA.
  • With the 510(k) clearance secured, Insight Medbotics will continue to advance IGAR to market.

Government of Canada Supports Research to Improve Brain Health

Retrieved on: 
Friday, April 28, 2023

The Government of Canada recognizes the importance of supporting the neuroscience community and its role in improving Canadians' brain health.

Key Points: 
  • The Government of Canada recognizes the importance of supporting the neuroscience community and its role in improving Canadians' brain health.
  • This funding is made possible through Health Canada's Canada Brain Research Fund (CBRF) Program, which has to date committed an overall federal investment of $200 million to Brain Canada Foundation in support of brain health discoveries.
  • "The Government of Canada recognizes the importance of supporting the neuroscience community and brain research as it plays a critical role in increasing our understanding of brain health conditions.
  • Brain Canada shapes its research priorities by engaging with the neuroscience community and bringing research stakeholders together to discuss and advance key brain health issues and opportunities in the health sector.

Ordr Announces Integration with ServiceNow Service Graph Connector Program

Retrieved on: 
Wednesday, March 22, 2023

SANTA CLARA, Calif. , March 22, 2023 /PRNewswire/ -- Ordr, the leader in connected device security, today announced it has joined the ServiceNow® Service Graph Connector Program by integrating its ServiceNow Connector for Ordr with Service Graph, helping customers to quickly, easily, and reliably load third-party data into the system, enabling data quality, timeliness and scalability.

Key Points: 
  • Ordr integrates with ServiceNow Service Graph Connector to improve connected device security, compliance and management.
  • Connectors validated by ServiceNow's Service Graph Connector Program integrate the expertise of the ServiceNow partner ecosystem into Service Graph.
  • For more information about the ServiceNow Connector for Ordr and how Ordr works with ServiceNow, visit https://ordr.net/partners/servicenow/ .
  • To learn even more, attend this Masterclass to deep-dive into the Ordr integration with ServiceNow Service Graph.

IDENTOS works with MedicaSoft to put healthcare data in motion

Retrieved on: 
Tuesday, November 8, 2022

Today, our healthcare systems are burdened with various health platforms that silo data and fail to deliver the necessary data to its required destination.

Key Points: 
  • Today, our healthcare systems are burdened with various health platforms that silo data and fail to deliver the necessary data to its required destination.
  • Healthcare providers want greater autonomy over patient data while maintaining confidentiality of the data being used and stored and having the ability to share it appropriately.
  • Powered by a translation engine that can transform data into standardized inputs compliant with all standards in today's healthcare market.
  • "In navigating the evolving healthcare data landscape, Delaware Health Information Network (DHIN) relies on the technical expertise, industry experience and excellent customer service consistently provided by the MedicaSoft team!

Canada's first and largest-scale vision-loss study is underway at St. Joe's thanks to $750,000 grant from the Juravinski Research Institute

Retrieved on: 
Monday, November 7, 2022

AMD is the leading cause of vision loss and legal blindness in Canadians aged 55 and older.

Key Points: 
  • AMD is the leading cause of vision loss and legal blindness in Canadians aged 55 and older.
  • study, it will leverage a randomized selection of retinal images and biomarkers from people (age 45-85) enrolled in the Canadian Longitudinal Study on Aging (CLSA) and other cohorts.
  • The research team will examine the images to measure and quantify the progressive disease at various stages over time.
  • The study is being led by Dr. Varun Chaudhary , Chief of Ophthalmology at St. Joe's and a professor of surgery at McMaster University.

Assure Holdings Performs First Neuromonitoring Case in New Jersey

Retrieved on: 
Friday, October 14, 2022

DENVER, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (IONM) and remote neurology services, is pleased to announce that it has performed its first neuromonitoring case in the state of New Jersey.

Key Points: 
  • DENVER, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (IONM) and remote neurology services, is pleased to announce that it has performed its first neuromonitoring case in the state of New Jersey.
  • Assure will be working with Marc J. Levine, M.D., who performs approximately 200 procedures annually.
  • A Clinical Assistant Professor at Rutgers New Jersey Medical School, he also serves as the Director of Orthopedic Spine Surgery at RWJBarnabas Healthcare-Hamilton.
  • Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services.

Ordr Improves Visibility, Security and Management of Connected Devices From Ground To Cloud

Retrieved on: 
Wednesday, September 21, 2022

SANTA CLARA, Calif., Sept. 21, 2022 /PRNewswire/ -- Ordr, the leader in connected device security, today announced new capabilities and enhancements to its AI-powered platform to help organizations discover, gain essential context, and secure their connected devices everywhere.

Key Points: 
  • Ordr announced enhancements to help organizations discover, gain essential context, and secure their connected devices.
  • Ordr 8.1 gives organizations comprehensive visibility into their entire attack surface, from ground to cloud.
  • For more information about how Ordr can help security and IT teams deliver visibility and security for their connected devices, from ground to cloud, please visit www.ordr.net .
  • Ordr makes it easy to secure every connected device, from traditional IT devices to newer andmore vulnerable IoT, IoMT, and OT.

Bay Area Health Trust receives Health Canada Interim Order Authorization for McMaster Molecular Medium

Retrieved on: 
Thursday, March 17, 2022

HAMILTON, ON, March 17, 2022 /CNW/ - Bay Area Health Trust has today announced its receipt of a Health Canada Interim Order (IO) authorization for its McMaster Molecular Medium (MMM).

Key Points: 
  • HAMILTON, ON, March 17, 2022 /CNW/ - Bay Area Health Trust has today announced its receipt of a Health Canada Interim Order (IO) authorization for its McMaster Molecular Medium (MMM).
  • "This announcement is a testament to the capabilities of the commercialization team at Bay Area Health Trust.
  • Bay Area Health Trust is also seeking US Food & Drug Administration authorization to enable broader opportunities within the US market.
  • Operating businesses with the goal of returning value to its beneficiaries, Hamilton Health Sciences, Hamilton Health Sciences Foundation and McMaster University, Bay Area Health Trust promotes entrepreneurship and invests in growth-oriented businesses to support patient care.

St. Joseph's Healthcare Hamilton Selects Spok Go® to Improve Connectivity Across the Health System

Retrieved on: 
Wednesday, April 14, 2021

Additionally, St. Joseph\xe2\x80\x99s Healthcare Hamilton is collaborating with Spok to help optimize Spok Go as a Clinical Innovation Partner.

Key Points: 
  • Additionally, St. Joseph\xe2\x80\x99s Healthcare Hamilton is collaborating with Spok to help optimize Spok Go as a Clinical Innovation Partner.
  • Joseph\'s Healthcare Hamilton (SJHH) is a leading research and academic health science centre located in the heart of Hamilton, Ontario.
  • St. Joseph\'s Healthcare Hamilton, a proud member of St. Joseph\'s Health System, is a teaching hospital affiliated with the world-renowned McMaster University.
  • For more information, visit spok.com or follow @spoktweets on Twitter.\nSpok is a trademark of Spok Holdings, Inc. Spok Go and Spok Care Connect are trademarks of Spok, Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210414005044/en/\n'